#
Title
1

Navigating the Impact of Preservatives in Ophthalmic Medications: Insights From Dr. Robert J. Noecker

2

Enhancing Patient Satisfaction through BAK-Free Solutions: Dr. Miriam Kolko's Vision for Preservative-Free Eye Care

3

Unveiling the Paradox: BAK's Role in American Pharmaceuticals With Dr. Nate Radcliffe

4

The European Approach to Preservative-Free Pharmaceuticals: A Conversation With Dr. Anton Hommer

5

Optics and Aberrations

6

Lens Lights Filters

7

Reducing Posterior Capsule Opacification

8

Innovations in Lens Technology and Visual Quality

9

Impact of Lens Materials on Optical Quality

10

Fundamentals of Lens Materials

11

Small-Aperture Technology

12

Understanding the Impact of Aperture Size on Vision

13

Best Practices on Communicating With Patients About Small-Aperture Technologies

14

Fundamentals of Small-Aperture Optics for Presbyopic Patients

15

Treating Meibomian Gland Dysfunction

16

Assessing Dry Eye Patients

17

Examining Lids: A Focus on Demodex Blepharitis and Blepharoptosis

18

Emergent Pharmaceutical Treatments for Dry Eye Diseases

19

Modern Interventional Treatments for Meibomian Gland Dysfunction

20

The Prevalence and Diagnosis of Meibomian Gland Dysfunction

21

Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 2

22

Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 1

23

Integrating Presbyopia Drops Into Optometric Practice

24

The Future of Presbyopia With Drops

25

IOL Selection in Presbyopes With Comorbid Conditions (Part 2)

26

IOL Selection in Presbyopes With Comorbid Conditions (Part 1)

27

Managing Presbyopic Cataract Patients With Comorbid Conditions

28

Communicating With Today’s Cataract Patients About Their Presbyopia-Correcting IOL Options

29

Managing Different MIGS Patients

30

Early Intervention With MIGS

31

The Burden of Glaucoma: How Noncompliance Impacts Patients and Doctors

32

Integrating Presbyopia Drops into Your Practice

33

The Future of Presbyopia with Drops

34

Keys to Effective Presbyopia Patient Conversations

35

The Newest Presbyopia Correcting IOLs

36

How to Bring Refractive Lens Exchange Into Your Practice

37

Identifying Refractive Lens Exchange Candidates

38

The Modern Refractive Lens Exchange Practice

39

Refractive Lens Exchange for Today’s Presbyopes

40

Premium IOL Selection for Hyperopic and Complex Cataract Patients

41

Incorporating Pharmaceutical Presbyopia Treatments Into Your Practice

42

Key Features of Pharmaceutical Presbyopia Treatments

43

Accessing That Leathery Posterior Plate - The Flip

44

Any Density Nucleus Horizontal Chop

45

Trenching to Transition to Horizontal Chop

46

Dense Cataract with Iridodialysis Repair

47

Managing a Traumatic Subluxed Cataract

48

The Challenge of Weak Zonules

49

Keratoconus and Blepharoptosis

50

Treating Meibomian Gland Dysfunction

51

Aqueous Dry Eye Treatment Recommendations

52

The Prevalence and Impact of Dry Eye Disease

53

ODs: Keratoconus Testing Consensus Roundtable: Part 3

54

ODs: Keratoconus Testing Consensus Roundtable: Part 2

55

ODs: Keratoconus Testing Consensus Roundtable: Part 1

56

MDs: Keratoconus Testing Consensus Roundtable: Part 3

57

MDs: Keratoconus Testing Consensus Roundtable: Part 2

58

MDs: Keratoconus Testing Consensus Roundtable: Part 1

59

Treating Flares vs. Chronic Dry Eye Disease

60

Diagnosing and Treating Dry Eye Flares

61

Definition and Impact of Dry Eye Flares

62

Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs

63

Next-Generation Presbyopia-Correcting IOLs

64

Innovations in Pharmacological Treatments for Presbyopic Patients

65

Welcome to Eyecare Innovations Today